Additional information
Here are numerical values from an out-patient and medically controlled field study.
Period of time – August 1998 to December 2003
Evaluation criteria according to the performance scale of Kutzke J.F.: Rating neurological impairment in MS: an expanded disability status scale (EDSS)
Neurology (1983), 33, 1444-1452
EDSS = 0 means healthy, 10 means dead
|
Year |
0 |
1 |
2 |
3 |
4 |
5 |
|
EDSS |
5,4 |
3,8 |
3,2 |
3,4 |
2,4 |
2,2 |
|
Number (s) |
52 |
47 |
46 |
32 |
15 |
14 |
After a neurologically provided diagnosis – subtypes:
|
Primary progressive subtype: |
n=17, average age 41,3 years (18 to 63 years) |
|
Relapsing-remitting subtype: |
n= 18, average age 37,8 years (23 to 56 years) |
|
Secondary progressive subtype: |
– n= 17, average 47,1 years (26 to 65 years) |
From the protocol of hindrance:
Criteria of performance capabilities – Walking
Begin of therapy:
|
Wheelchair = WC |
crutches = C |
Walking = WK |
|
(n=18) |
(n=13) |
(n=21) |
|
|
WC->C |
C->WK |
WC->WK |
WC->WC |
C->C |
C->WC |
WK->C |
|
1.year |
10 |
10 |
5 |
3 |
3 |
|
|
|
2.year |
3 |
2 |
|
2 |
9 |
1 |
|
|
3.year |
2 |
5 |
|
4 |
11 |
|
2 |
|
4.year |
|
3 |
|
2 |
2 |
1 |
|
|
5.year |
|
|
2 |
3 |
|
|
|
In a space of 5 years, 3 neurological verified relapses were reported, which in accordance to the corresponding recommendations of the DMSG were treated in the patients home towns. 14 patients had an EDSS = 0. 12 patients broke off the therapy in this space of time.